// App-Quantinova.ai

753 : The use of proteomics to analyse whole tumors and identify unique stroma cell targets for antibody-based therapeutics

Researchers

Presenter

  • James Ackroyd

Principal Investigators

  • Jason Allen

  • Jo Berry

  • Lisa Roesch

  • Martin Barnes

  • Arnima Bisht

  • Christian Rohlff

  • Keith Wilson

  • Dee Aud

  • Robert Boyd

Medical Centers

  • PsiOxus Therapeutics Ltd., Abingdon, United Kingdom

  • Oxford BioTherapeutics Inc, San Jose, CA

Locations

  • United States

  • United Kingdom

Companies

  • Oxford Biotherapeuti

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved